The invention disclosed herein is a nanodispersion formulation for ocular drug delivery comprising poorly water soluble drug(s), mineral oil, surfactant(s), optionally permeation enhancer and other pharmaceutical acceptable excipients, with improved patient compliance, reduced dosing frequency, safety and better therapeutic efficacy, and process for preparation of the nanodispersion.